NCT02605850

Brief Summary

This study will determine the effects of beneficial compounds of plant foods, such as pomegranate on cardiovascular health. This will be tested by asking healthy males to eat a high fat ground beef patty with pomegranate juice (PJ), pomegranate extract (PomX) or water and then measuring blood vessel dilation (endothelial function) by blood flow We also will measure the amount of Nitric Oxide (NO) in your blood and urine samples and sugar and insulin in blood. Healthy men have been chosen for this study because eating high fat hamburger patties can easily mimic in them the condition that causes atherosclerosis. The results from this study may help to explain how high fat foods can be harmful to the body and how beneficial plant foods can have on cardiovascular function

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Jan 2016

Shorter than P25 for not_applicable cardiovascular-diseases

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 16, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

8 months

First QC Date

October 12, 2015

Last Update Submit

December 30, 2019

Conditions

Keywords

heart health

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Abnormal PAT Values That Are Related to Treatment

    The major outcomes are PAT changes after a test meal with and without pomegranate.

    Change from Baseline vascular function at 6 weeks

Secondary Outcomes (1)

  • Number of Participants With Abnormal Laboratory Values That Are Related to Treatment

    Change from Baseline laboratory values at 6 weeks

Study Arms (3)

Ground beef patty + Water

PLACEBO COMPARATOR

32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.

Other: Water

Ground beef patty + Pomegranate Extract

ACTIVE COMPARATOR

32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.

Dietary Supplement: Pomegranate extract

Ground beef patty + Pomegranate Juice

ACTIVE COMPARATOR

32 healthy subjects, ages 18-35 years who meet all the eligibility criteria in the screening phase of the study will receive the ground beef patty + water to evaluate the clinical efficacy of pomegranate on vascular health.Then subjects will be randomized to consume pomegranate juice or extract. At visit 2, subjects will be tested before and after meal with pomegranate juice or extract, then take pomegranate product daily for 4 weeks. At visit 3, subjects will tested before and after test meal with pomegranate products.

Dietary Supplement: Pomegranate Juice

Interventions

WaterOTHER

All subjects will consume ground beef patty meal with water at the baseline visit.

Ground beef patty + Water
Pomegranate JuiceDIETARY_SUPPLEMENT

Pomegranate Juice will be taken 1/day for 4 weeks.

Also known as: PJ
Ground beef patty + Pomegranate Juice
Pomegranate extractDIETARY_SUPPLEMENT

Pomegranate extract will be taken 1/day for 4 weeks.

Also known as: PomX
Ground beef patty + Pomegranate Extract

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old males (inclusive)
  • Non-smokers
  • Must weigh a minimum of 110 pounds
  • Willing to maintain normal activity and eating patterns for the duration of the study
  • Willing to maintain their normal diet for the duration of the study but avoid pomegranate products and ellagitannin rich foods.

You may not qualify if:

  • Any chronic medical conditions
  • Abnormal liver function (AST and ALT \> 2 x upper limit)
  • Currently taking steroidal drugs
  • Cancer treated within the past two years
  • Participation in a therapeutic research study within 30 days of baseline
  • Use of antibiotics within one month
  • Regular use of probiotics
  • Allergy or sensitivity to pomegranate products
  • Follow a vegetarian diet
  • Known HIV positive

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801-9. doi: 10.1038/362801a0.

    PMID: 8479518BACKGROUND
  • Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. doi: 10.1161/01.atv.0000051384.43104.fc.

    PMID: 12588755BACKGROUND
  • Kasprzak JD, Klosinska M, Drozdz J. Clinical aspects of assessment of endothelial function. Pharmacol Rep. 2006;58 Suppl:33-40.

    PMID: 17332669BACKGROUND
  • Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995 Feb 23;75(6):71B-74B. doi: 10.1016/0002-9149(95)80017-m.

    PMID: 7863979BACKGROUND
  • Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985). 2006 Aug;101(2):545-8. doi: 10.1152/japplphysiol.01285.2005. Epub 2006 Apr 13.

    PMID: 16614356BACKGROUND
  • Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST, Lerman A. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003 May 21;41(10):1761-8. doi: 10.1016/s0735-1097(03)00329-2.

    PMID: 12767662BACKGROUND

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Waterpomegranate fruit rind

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Zhaoping Li, MD, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

October 12, 2015

First Posted

November 16, 2015

Study Start

January 1, 2016

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

IPD will not be shared with other researchers.